Milestone also announced the extension of its $75 million Royalty Purchase Agreement with RTW Investments
IGI partners with AbbVie and grants exclusive rights to globally develop, manufacture, and commercialize ISB 2001 across North America, Europe, Japan, and Greater China
It is intended for contrast enhancement in MRI scans
The FDA set a target action date of April 28, 2026, under the Prescription Drug User Fee Act
Additional data will be presented on a once-weekly oral combination of islatravir and ulonivirine (ISL/ULO) for HIV-1 treatment
The companies admitted taking part in the cartel in exchange for reduced fines but Alchem did not settle
The company has confirmed that the deceased are 39
The company's decision to withdraw the MAA was due to the timing of the availability of Chemistry Manufacturing and Controls
Innovative agents highlight growth of targeted protein degradation platform and BMS' leadership in innovative cancer therapies
Prasinezumab is a potential first-in-class anti-alpha-synuclein antibody, targeting a known biological driver of Parkinson’s disease progression
Subscribe To Our Newsletter & Stay Updated
